Is colorectal surveillance indicated in patients with PTEN mutations?

M. H. Nieuwenhuis, C. M. Kets, M. Murphy-Ryan, C. Colas, P. Moller, F. J. Hes, S. V. Hodgson, M. J. W. Olderode-Berends, S. Aretz, K. Heinimann, E. B. Gomez Garcia, F. Douglas, A. Spigelman, S. Timshel, N. M. Lindor, H. F. A. Vasen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e562-e566
JournalColorectal Disease
Volume14
Issue number9
DOIs
Publication statusPublished - Sep 2012

Keywords

  • PTEN phosphohydrolase
  • multiple hamartoma syndrome
  • colorectal neoplasms

Cite this

Nieuwenhuis, M. H., Kets, C. M., Murphy-Ryan, M., Colas, C., Moller, P., Hes, F. J., Hodgson, S. V., Olderode-Berends, M. J. W., Aretz, S., Heinimann, K., Gomez Garcia, E. B., Douglas, F., Spigelman, A., Timshel, S., Lindor, N. M., & Vasen, H. F. A. (2012). Is colorectal surveillance indicated in patients with PTEN mutations? Colorectal Disease, 14(9), e562-e566. https://doi.org/10.1111/j.1463-1318.2012.03121.x